Strides Pharma Science Limited

NSE:STAR.NS

1549.6 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Omzet 40,511.2436,883.8730,220.5632,511.5526,567.4529,437.8627,965.2133,557.2830,310.8911,320.2110,727.68822,044.7225,245.1916,958.4413,047.7110,203.317,256.127,429.845,237.184,485.26
Kosten van de omzet 26,123.1316,268.8515,832.8414,087.811,839.8215,040.1314,244.5315,428.515,307.225,604.826,151.0569,980.1314,763.658,784.247,565.55,867.654,176.863,846.122,407.322,270.78
Brutowinst 14,388.1120,615.0214,387.7218,423.7514,727.6314,397.7313,720.6818,128.7815,003.675,715.394,576.63212,064.5910,481.548,174.25,482.214,335.663,079.263,583.722,829.862,214.48
Brutowinstmarge 0.3550.5590.4760.5670.5540.4890.4910.540.4950.5050.4270.5470.4150.4820.420.4250.4240.4820.540.494
Onderzoek- en ontwikkelingskosten 595.44638.65893.881,059.11,039.651,285.831,189.931,575.081,906.46393.91,129.12000000000
Algemene en administratieve kosten 7,668.861,476.831,512.081,151.251,1511,062.32944.981,017.12880.88404.47305.312587.042,270.091,639.171,162.711,177.831,177.9780.85640.53478.4
Verkoop- en marketingkosten 365.32,636.513,312.972,232.18166.61607.39852.28763.3506.78271.06533.4276.46476.24388.26357.39334.82206.46193.61135.1492.29
Verkoop-, algemene en administratieve kosten 9,162.34,113.344,825.053,383.431,317.611,669.711,797.261,780.421,387.66675.532,328.856863.52,746.332,027.431,520.11,512.651,384.36974.46775.67570.69
Overige kosten 397.0118,745.7311,980.1810,827.619,746.67135.85203.07105.1898.07150.150101.284,401.192,822.542,348.97-1,060.59882.11,535.881,120.65796.59
Bedrijfskosten 9,162.318,745.7316,805.2314,211.0411,064.2811,454.2611,295.5513,304.4911,311.343,924.093,458.1527,122.567,147.524,849.973,869.07452.062,266.462,510.341,896.321,367.28
Bedrijfsresultaat 5,225.81-796.99-2,824.274,569.212,081.62,943.472,425.134,824.293,692.331,791.31,598.4164,942.033,334.023,324.231,613.143,883.6812.81,073.38933.54847.2
Bedrijfsresultaat ratio 0.129-0.022-0.0930.1410.0780.10.0870.1440.1220.1580.1490.2240.1320.1960.1240.3810.1120.1440.1780.189
Totaal overige inkomsten en kosten netto -4,637.89-2,065.01-3,700.86-1,814.82-1,534.8-2,222.92-1,625.66-1,853.36-1,116.75-305.52-864.4244,552.87-607.16-1,460.51-183.77-2,734.81-1,158.49-408.03-341.27-306.3
Inkomen voor belasting 587.92-2,862-6,525.132,754.39546.8720.55799.472,970.932,575.581,485.78733.9929,494.92,726.861,863.721,429.371,148.79-345.69665.35592.27540.9
Inkomen voor belasting ratio 0.015-0.078-0.2160.0850.0210.0240.0290.0890.0850.1310.0680.4310.1080.110.110.113-0.0480.090.1130.121
Belastingkosten 315.9-553.01-1,782.63316.51113.23131.2297.33470688.55532.32,596.2961,021.45386.8451.94218.99107.94170.85173.5334.25123.85
Nettowinst -1,248.34-2,308.99-4,742.52,684.42363.913,246.186,604.693,997.492,089.368,449.99-1,867.0568,462.372,244.751,224.471,096.831,079.63-501.21402.29485.64439.98
Nettowinstmarge -0.031-0.063-0.1570.0830.0140.110.2360.1190.0690.746-0.1740.3840.0890.0720.0840.106-0.0690.0540.0930.098
WPA (Winst Per Aandeel) -13.65-25.63-52.8428.42.736.2573.8144.7313.14141.85-31.55144.338.5526.1126.4926.91-5.610.5513.4313.13
Verwaterde WPA -13.62-25.63-52.8428.372.736.2473.7944.6413.06141.27-31.55131.8538.3224.5619.6724.7-5.69.3312.1713.13
EBITDA 7,432.641,635.53-494.136,632.083,959.513,580.314,489.578,115.435,696.392,389.642,050.2645,285.415,292.443,957.221,530.716,175.81,751.671,409.561,179.811,061.38
EBITDA ratio 0.1830.044-0.0160.2040.1490.1220.1610.2420.1880.2110.1910.240.210.2330.1170.6050.2410.190.2250.237